Alphatec Holdings Inc
NASDAQ:ATEC

Watchlist Manager
Alphatec Holdings Inc Logo
Alphatec Holdings Inc
NASDAQ:ATEC
Watchlist
Price: 9.3 USD -0.53% Market Closed
Market Cap: $1.4B

EV/GP

3.4
Current
39%
Cheaper
vs 3-y average of 5.5

Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.

EV/GP
3.4
=
Enterprise Value
$2.2B
/
Gross Profit
$531.9m

Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.

EV/GP
3.4
=
Enterprise Value
$2.2B
/
Gross Profit
$531.9m

Valuation Scenarios

Alphatec Holdings Inc is trading below its 3-year average

If EV/GP returns to its 3-Year Average (5.5), the stock would be worth $15.19 (63% upside from current price).

Statistics
Positive Scenarios
4/4
Maximum Downside
No Downside Scenarios
Maximum Upside
+102%
Average Upside
78%
Scenario EV/GP Value Implied Price Upside/Downside
Current Multiple 3.4 $9.3
0%
3-Year Average 5.5 $15.19
+63%
5-Year Average 6.8 $18.83
+102%
Industry Average 5.2 $14.29
+54%
Country Average 6.5 $18.07
+94%

Forward EV/GP
Today’s price vs future gross profit

Not enough data available to calculate forward EV/GP

Peer Comparison

All Multiples
EV/GP
P/E
All Countries
Close
Market Cap EV/GP P/E
US
Alphatec Holdings Inc
NASDAQ:ATEC
1.4B USD 3.4 -9.9
US
Intuitive Surgical Inc
NASDAQ:ISRG
161.2B USD 23.4 56.4
US
Abbott Laboratories
NYSE:ABT
158.6B USD 6.3 25.3
US
Stryker Corp
NYSE:SYK
120.5B USD 8.1 37.1
IE
Medtronic PLC
NYSE:MDT
101.9B USD 5.2 22.1
US
Boston Scientific Corp
NYSE:BSX
84.8B USD 6.6 23.8
US
Edwards Lifesciences Corp
NYSE:EW
47.2B USD 8.9 43
US
IDEXX Laboratories Inc
NASDAQ:IDXX
44.1B USD 16.7 41.7
DE
Siemens Healthineers AG
XETRA:SHL
38.3B EUR 5.1 18.1
US
Becton Dickinson and Co
NYSE:BDX
41.4B USD 5.7 23.5
US
Resmed Inc
NYSE:RMD
30.9B USD 9.1 20.8

Market Distribution

Lower than 78% of companies in the United States of America
Percentile
22nd
Based on 9 428 companies
22nd percentile
3.4
Low
0 — 4.2
Typical Range
4.2 — 10.6
High
10.6 —
Distribution Statistics
the United States of America
Min 0
30th Percentile 4.2
Median 6.5
70th Percentile 10.6
Max 1 764 211.7

Alphatec Holdings Inc
Glance View

Market Cap
1.4B USD
Industry
Health Care

Alphatec Holdings Inc., often recognized under its brand ATEC, is a dynamic entity within the spinal solutions market. The company, based in Carlsbad, California, has passionately committed to transforming spinal surgeries, focusing on surgical innovation to solve the most persistent challenges faced by surgeons. ATEC started with a vision to shake up the staid, conventional spine surgery landscape by leveraging technology to improve surgical techniques and patient outcomes. This commitment to innovation is evident in its robust pipeline of products designed for various spinal disorders and conditions. By investing heavily in research and development, ATEC consistently brings to market cutting-edge solutions that align with its goal of revolutionizing surgical spine treatment. Its approach to problem-solving sets it apart: rather than an off-the-shelf attitude, ATEC works closely with surgeons to create tailored solutions that meet the individualized needs of their patients. The financial engine of Alphatec revolves around the commercial reach of its proprietary spinal hardware and biologics portfolio. The company taps into a growing demand for advanced spinal surgery technologies, channeling its expansive product line through its sales team and collaboration with distribution partners. Revenues primarily stem from product sales, where the integration of new technologies such as its AlphaInformatiX platform, an integrated software suite, enhances the surgical experience through real-time analytics and visualization, creating additional value for healthcare providers. By focusing on high-margin, innovative products, while continually expanding its distribution networks and scaling its operations to meet increasing demand, ATEC positions itself as an essential player with the potential for sustainable revenue growth in the competitive spine surgery market.

ATEC Intrinsic Value
13.24 USD
Undervaluation 30%
Intrinsic Value
Price $9.3
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett